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The efferent vessel of hepatocellular carcinoma (HCC) and the mechanism and pathogenesis of the high
frequency of intrahepatic metastasis in HCC has not yet been clarified. Three hundred ninety-three resected
specimens ofHCC were examined for tumor thrombosis in the portal vein and the hepatic vein: 231 tumors
<-5 cm in diameter were examined for the relationship between mode oftumor spread and tumor size. Efferent
vessels in HCC were identified by direct injection of radiopaque material into the tumor in 23 resected liver
specimens and by percutaneous infusion of radiopaque media into tumor nodules in 8 patients. The mode of
tumor spread in HCC progressed from capsular invasion to extracapsular invasion, then to vascular invasion,
and finally to intrahepatic metastasis. There was a strong statistical correlation between the presence of
intrahepatic metastasis and portal vein thrombosis (p<0.05, R=0.998). Radiopaque material injected directly
into 23 resected tumors entered only the portal vein in 17 tumors and into both the portal and hepatic veins in
6 tumors. In all 8 patients with unresectable lesions, radiopaque media injected percutaneously into tumor
nodules flowed only into the portal vein. These findings suggest that intrahepatic invasion byHCC may occur
through the portal vein as an efferent tumor vessel.
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INTRODUCTION
The prognosis ofhepatocellular carcinoma (HCC) has
improved in recent years. This is the result of refined
surgical techniques, early detection ofsmall tumors by
advances in imaging techniques and biochemical diag-
nosis, and the introduction of percutaneous arterial
embolization and ethanol infusion therapy.
1-5 How-
ever, the prognosis of HCC remains relatively poor
because of the high frequency of multiple hepatic
tumors, although patients rarely have distant metas-
tases at the time of surgery 1’ 6, 7.
There are some cases of multicentric origin7’ 8, how-
ever, multiple lesions in HCC have been attributed to
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intrahepatic metastases 1’5’9-12 because HCC has a high
frequency of tumor invasion into the portal vein sys-
tem. The mechanism and pathogenesis of the high
frequency of intrahepatic metastasis and portal inva-
sion in HCC has not yet been clarified. To investigate
the mechanism of intrahepatic metastasis and portal
invasion, the pathological, radiological, and morpho-
logical studies were undergone to evaluate the efferent
tumor vessels in HCC.
MATERIALS AND METHODS
Four hundred and seventy-two patients with HCC
underwent resection between April 1980 and
December 1993 in our department; of those patients,
393 who underwent subsegmentectomy or larger re-
section were selected for entry into the study. The
other patients who had smaller resection than subseg-
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mentectomy, such as enucleation of the tumor or
wedge resection of the tumor due to liver dysfunction
were excluded from the study, because intrahepatic
metastatic lesions could not be examined adequately.
The resected specimens were sliced at a thickness of
about cm, and all of the slices were macroscopically
examined for tumor thrombosis in the portal and
hepatic veins. Two to three slices including the maxi-
mum cut-surface of the tumor were histologically
examined over the total cut-surface. The frequency of
capsular invasion, extracapsular invasion, vascular
invasion, and intrahepatic metastasis were noted. Tis-
sues were fixed in 10% buffered formalin and
embedded in paraffin, processed routinely, and stai-
ned with hematoxylin and eosin. Selected sections
were stained with periodic acid-Schiff (PAS), Masson
trichrome, elastica-van Gieson, and silver impregnation.
Of the 393 total specimens, 231 showed tumors -<5
cm in diameter. Of these, 23 (10%) were selected at
random for radiographic evaluation. Radiopaque
media was manually infused directly into the tumor
immediately after hepatectomy using a 27 gauge nee-
dle with a low injection pressure and specimen radio-
graphs were obtained. Specimens were then fixed and
serially sectioned, and efferent tumor vessels were
histopathologically evaluated. In 7 specimens, radio-
paque media was infused into the portal vein, and the
vasculature ofthe portal system around the tumor was
evaluated in a similar fashion. In 3 specimens, molds
of efferent tumor vessels were produced by infusing
silicon rubber directly into the resected tumor.
In 8 patients with unresectable lesions, because of
the advanced stage of the tumor or the advanced
cirrhotic stage, radiopaque media was infused into the
tumor by direct percutaneous puncture using an ultra-
sound guided puncture technique and efferent tumor
vessels were observed. Subsequently percutaneous
administration of chemotherapy with Adriamycin or
percutaneous ethanol injection were conducted. The
infusion of the radiopaque media into the tumor was
approved by the Human Ethics Committee of the
Hyogo College of Medicine, and written informed
consent was obtained from each patient.
Statistical Analysis
Differences in proportion between groups were made
using chi square test or Fisher’s exact test. The
correlation between the presence of vascular invasion
and intrahepatic metastasis was evaluated by correla-
tion analysis. P<0.05 was regarded as significant.
RESULTS
Histopathologic Findings
The overall incidence of macroscopic intrahepatic
metastasis was 205 of the 393 resected cases (52.1%).
None had evidence of lung or bone metastasis at the
time of surgery. Lymph node metastasis was also
uncommon (1.6%) in the 393 cases.
When multiple intrahepatic tumors were present,
the primary lesion was easily identified in all cases.
Daughter nodules were generally smaller, peripheral
to the primary tumor, and situated in the same portal
branch area as the main tumor. Tumors tended to
invade the portal vein and metastasize extensively
even when the primary lesion was small and especially
when it was located near the main trunk of the portal
vein. Portal vein tumor thrombosis was observed in 73
cases (18.6%) macroscopically, while, tumor throm-
bosis ofthe hepatic vein was confirmed in only 12 cases
(3.1%). Among the 12 cases, 11 also had extensive
tumor thrombosis of the portal vein.
The pathology of HCC growth appeared to occur
by expansion and compression ofsurrounding tissues.
An abundant vascular network was noted in tumor
capsules, and communicating branches between blood
spaces in the tumor and this vascular network were
observed in all cases. Serial sections showed that
tumor cells were disseminated through these commu-
nicating branches and were also present within the
vascular network ofthe capsule in most ofthe resected
specimens. Tumor cells also were often noted within
extracapsular blood vessels. Tumor cell infiltration to
the intra- and extracapsular blood vessels was seen at
many sites of all circumference (Figure 1).
The mode of tumor spread was histologically ana-
lyzed among 231 tumors -<5 cm in diameter. Intra-
capsular invasion, which included isolated invasion of
the vascular network of the capsule, was observed in
99.1% of cases. Extracapsular invasion was observed
in 60.6% of HCC tumors <2.0 cm, in 76.3% of those
2.1 to 3.0 cm, and in 81.9% of those 3.1 to 5.0 cm in
diameter. Invasion of pericapsular vessels (vascular
invasion) was observed in 48.4% ofHCC tumors <2.0
cm, in 59.1% of those 2.1 to 3.0 cm, and in 73.3% of
those 3.1 to 5.0 cm in diameter. Thus, the larger the
tumor size, significantly the higher was the frequency
of extracapsular invasion, vascular invasion and
intrahepatic metastasis. Metastasis to liver paren-
chyma was observed in 36.3% of HCC tumors <2.0
cm, in49.4% ofthose 2.1 to 3.0 cm, and in 70% ofthose
3.1 to 5.0 cm in diameter (Table 1).INTRAHEPATIC METASTASIS OF HCC 99
Evaluation ofHCC Efferent Veins
Radiopaque media infused directly into tumors less
than or equal to 5 cm in diameter allowed clear visuali-
zation of the pericapsular vascular network in 23
Figure 1 (A) Microscopic finding of hepatocellular carcinoma in-
vading into vascular channels (VC) of the tumor capsule. Tumor
thrombi (white arrow) in the vascular channel of the tumor capsule
are clearly identified (B). Fine communicating vessels (black arrow)
between the vascular channels in the capsule and the blood space in
the tumor also are observed (H&E stain; magnification x 100).
resected specimens. In 17 (74%) of 23 specimens, por-
tal branches were fully visualized, while hepatic vein
branches were not filled at all (Figure 2). In the other
six cases (26%), both portal and hepatic vein branches
were opacified, but the portal vein branch was always
filled more predominantly than the hepatic vein branch.
Thus, when the radiopaque media was infused into the
tumors, the media flowed out in significantly higher rate
into portal branches than into hepatic vein branches
(p<0.05). In 3 minuteHCCs out of23 with an incomplete
capsule, radiopaque media also drained directly into the
surrounding noncancerous sinusoids at the site without
a capsule and into portal branches at the portion with a
capsule (Table 2). In the 23 resected specimens, 16 were
histologically cirrhotic and 7 were noncirrhotic in the
noncancerous liver. In the 16 tumors with cirrhotic liver
14 (87.5%) had visualization ofonly portal vein branches
and 2 (12.5%) showed opacification of both the portal
and hepatic vein branches, while in the 7 tumors with
noncirrhotic liver 3 (42.8%) showed visualization ofonly
portal vein branches and 4 (57.1%) revealed opacification
ofboth the portal and hepatic vein branches.
Direct portal infusion of the contrast media in the 7
resected specimens clearly demonstrated the vascular
network of the capsule and abundant portal branches
surrounding the tumors; however, radiopaque media
did not enter the tumor in all the cases (Figure 3).
Siliconized rubber was infused into the tumor in
three cases, and the interior of the tumor and the
portal system around the tumor were visualized.
Many portal branches around the tumor capsule
penetrated directly into the interior of the tumor via
fine communicating vessels (Figure 4).
The portal system around the primary tumor was
examined radiographically in 8 patients with unresec-
table HCC by infusing radiopaque media directly into
Table Tumor size and degree of tumor invasion.
Tumor size Capsular
(cm) invasion
Histopathology oftumor spread
Extracapsular Vascular* Intrahepatic*
invasion invasion metastasis
0-2.0 33 cases 32/33 20/33 16/33 12/33
(97.0%) (60.6%) (48.5%0) (36.4%0)
2.1-3.0 93 cases 92/93 71/93 55/93 46/93
(99.0%) (76.3%) (59.1%) (49.5%)
3.1-5.0 105 cases 105/105 86/105" 77/105 74/105
(100.0%0) (81.9%) (73.3%) (70.5%)
Total 231 cases 229/231 177/231 148/231 132/231
(99.1%) (76.6%) (64.1%) (57.1%)
ap < 0.05 compared to 0-2.0 cm tumors
bp < 0.05 compared to 0-2.0 and 2.1-3.0 cm tumors
*Correlation between vascular invasion and intrahepatic metastasis (correlation
coefficient 0.998, p <0.05100 A. TOYOSAKA et al.
Figure 2 Radiopaque media (RM) injected directly into a small hepaticellular nodule in the resected liver (upper left) demonstrated
communication between the vascular channels in the tumor capsule and the bloodspace in the tumor (T) via fine vessels (lower left, 100).
The portal vein (PV) was clearly visualized by radiography and the radiopaque media was identified in the portal vein and the
communicating vessel (arrows) on histologic examination (right, 100).
(BD: Bile duct; HA: Hepatic artery)
the tumor by the percutaneous transhepatic route
(Figure 5). The portal venous branches around the
tumor was fully opacified, while the hepatic vein was
opacified only faintly.
DISCUSSION
Autopsy-based studies ofHCC generally reveal many
daughter (satellite) nodules; a single tumor is rare.
Multiple tumor nodules in the liver have been assumed
to be multicentric in origin since regenerative nodules
in the setting of cirrhosis may frequently transform
to HCC and because experimental HCC has been
described as multicentric6’7. However, recent advances
in imaging techniques have allowed detection of
single, small, and often subclinical lesions. Early
resection of such lesions has increased the long-term
survival in several studies-5’ 9-11, 13. Daughter nodules
could also be regarded as intrahepatic metastases
since HCC has a high frequency of invasion into the
portal venous system1’5’9’1. However, it remains diffi-
cult, even utilizing tests ofDNA ploidy and clonicity
to define accurately whether multiple tumors in HCCs
are multicentric or metastatic lesions, because these
tumors are characteristically heterogeneous.
Our study supports the notion that most daughter
nodules are intrahepatic metastases. First, a definite
primary lesion was present in all resected specimens,
even when multiple tumors were present. Second,
distinct daughter nodules were frequently found in the
same portal branch area or an adjacent area. How-
ever, the most important finding was macroscopic
thrombi in the portal vein in 18.3% of 393 cases and in
the hepatic vein in only 3.1%. The reported incidence
of tumor thrombi in intrahepatic vessels in HCC
ranges from 47.6% to 91.8/04’5. In reports that de-
scribed tumor thrombosis of both the portal and he-
patic venous systems, the incidence in the portal
system varied from 23.9% to 90.2% and in the hepatic
venous system from 3.7% to 15.2%5,15-7. Anyway the
incidence of invasion of the portal system was always
higher. In our series, the mode of tumor spread was
analyzed among tumors -<5 cm in diameter. These
results suggest that serial tumor spread starts with
intracapsular invasion, progresses to extracapsularINTRAHEPATIC METASTASIS OF HCC 101
Table 2 Roentgenographic findings in the 23 resected specimens in which radiopaque
media was infused directly into the tumor -<5 cm in diameter.
Visualization Visualization
Age/ Tumor size Noncancerous of of
Case Sex (cm) condition portal vein hepatic vein
1. 51 M 5.04.5 cirrhosis #
2. 60 M 4.53.0 #
3. 60 M 4.84.0 chronic hepatitis # +
4. 50 M 3.23.0 cirrhosis
5. 48 F 3.02.5
6. 36 F 5.04.5 normal +
7. 57 M 2.52.3* cirrhosis
8. 47 F 4.84.7 chronic hepatitis
9. 54 M 5.04.6 normal +
10. 52 M 3.02.5 cirrhosis
11. 59 F 3.73.5
12. 52 M 1.9 1.8’ cirrhosis
13. 51 F 4.94.8 chronic hepatitis +
14. 48 M 1.8 1.7" cirrhosis
15. 49 M 3.22.9
16. 55 M 4.64.0 chronic hepatitis
17. 61 M 2.0 1.9 cirrhosis
18. 63 M 2.92.6
19. 46 F 4.54.1 +
20. 59 M 3.3x3’1 +
21. 66 M 3.63.3
22. 60 F 5.0x4.8 chronic hepatitis
23. 53 M 2.52.3 cirrhosis #
The frequency of visualization
of portal and hepatic veins
23/23 6/23
(100/0) (26.1%)
p < 0.05 (a vs b)
*The media drained directly into the surrounding noncancerous sinusoids at sites without a
capsule
Figure 3 Following injection of radiopaque media into the portal
vein (PV) of resected specimen with hepatocellular carcinoma, a
rich vascular network (arrows) was visualized around the tumor
(T).
invasion, intravascular invasion, and finally to
intrahepatic metastasis. Vascular invasion was ob-
served in about one halfand intrahepatic metastasis in
one third of the tumors <2 cm, suggesting that HCC
can invade the intrahepatic vascular system, especially
the portal vein, at an early stage.
In our study, when radiopaque media was infused
into the tumor, the media flowed immediately into
portal vessels around the tumor with little resistance.
The utilization of the portal vein as an efferent vessel
was more marked when HCC was superimposed on
cirrhosis. This finding was expected because of the
impaired drainage by the hepatic vein in cirrhotic
livers. This communication with the portal circulation
in HCC could also be responsible for the early occur-
rence of intrahepatic metastasis in cirrhotics.
Nakashima TM has proposed that tumor thrombosis of
the portal vein occurs at an early stage because the
portal vein may act as the primary efferent vessel for
HCC.
One possible objection may be that this study only
proves that there were communications between the
portal branches and the tumor, but cannot show that
the portal vein serves as an efferent vessel. However,
when contrast medium was injected into the tumor
using a low injection pressure, contrast media entered
the tumor with little resistance and flowed immedi-
ately out into the portal branches, suggesting that the
contrast media was injected into vessels. Arterio-
graphy of HCCs generally shows hypervascularity.102 A. TOYOSAKA et al.
Figure 4 A mold produced by direct infusion of siliconized rubber
into an encapsulated hepatocellular carcinoma measuring 4 5 cm.
The vascular network around the tumor (arrows) and the portal
venous system (PV) is shown.
Abundant flow from the hepatic artery feeds the
tumor, and arterial blood flows through the blood
space into the tumor. Therefore, the pressure ofblood
flow into the tumor is much higher than that of the
portal vein. Moreover, direct portal infusion of con-
trast media did not enter the tumor, although the
portal area surrounding the tumor was fully opacified.
Therefore we propose that the portal venous flow
cannot enter the tumor, but serves only as an efferent
vessel, and that the arterial vessels ordinarily serve as
afferent vessels. The current study is the first in which
efferent vessels in HCC were identified by direct infu-
sion of radiopaque material into the tumor.
Our data suggests that efferent vessels penetrating
the tumor capsule are the path of least resistance for
tumor escape. We showed that tumor cells can invade
efferent vessels, were engorged in the vascular cavity,
and extend beyond the capsule to branches of the
portal vein. This may be the major mechanism for the
formation of tumor thrombi within the portal vein. It
is also hypothesized that tumor fragments may
disseminate via portal vein branches to form periph-
eral intrahepatic metastatic lesions. Tumor thr0mbi
generally are fed by an artery ofthe primary tumor 15’18.
However, when thrombi of tumor fragments detach
from the tumor and flow into the portal blood stream,
they can survive in the portal blood. Then, they adhear
to the portal vein wall and obtain their blood supply
from the surrounding arterioles. Thus, the portal vein
acts as a viable conduit for drainage of the blood
feeding the tumor and even for tumor infiltration and
spread. (Figure 6).
Our data demonstrates the presence of an arterio-
portal (A-P) shunt in all HCCs, even in subclinical
tumors and tumors without portal vein thrombosis.
However, an A-P shunt is not detectable by conven-
tional angiography in cases with a minor or no tumor
thrombosis in the portal vein. But it can be often
detectable in cases with a macroscoptic tumor throm-
bus. In this series, all the cases with an A-P shunt
ili!iiiiii::ii:.’.:::::..’::;:
tumor cell mass
/y::i::,,.m, within the
vascular cavity
r cavity
Figure 5 Following injection of radiopaque media into a hepato-
cellular carcinoma (T) by the ultrasound guided percutaneous
transhepatic puncture technique, the portal drainage system (PV)
was visualized.
Figure 6 Schematic drawing the vascular architecture in HCC. The
hepatic artery is the feeding vessel, and the portal vein serves mainly
as an efferent vessel. The efferent vessels penetrating the capsule are
the path with least resistance for tumor infiltration or expansion.
Tumor cells invade efferent vessels by budding, extension to the
vascular cavity and extend beyond the capsule to the portal vein
branches. (HA: Hepatic artery; PV: Portal vein; HV: Hepatic vein)INTRAHEPATIC METASTASIS OF HCC 103
demonstrated by angiography had tumor thrombi in
the major portal venous branches. When the tumor
involves the portal vein, the arterial blood in the tumor
naturally follows a pressure gradient and flows into
the portal vein from the site ofportal vein thrombosis.
Therefore, A-P shunts may indicate the presence of
tumor thrombi in the portal vein.
In summary, our findings suggest that the portal vein
serves as an efferent vessel in HCC, rather than a supply
vesselas suggested by others 19. We hypothesize that this
relationship accounts for the high frequency of portal
vein thrombosis and intrahepatic metastasis in HCC.
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COMMENTARY
Hepatocellular carcinoma (HCC) accounts for more
than million deaths each year worldwide 1. This
tumour has two very interesting features which make
the prognosis extremely poor. First, the operability
rate is low, and second, intrahepatic recurrence is high
after a successful hepatic resection.
Around 80 to 90 per cent of patients with HCC
have inoperable tumours at the time of clinical
presentation2. This is related to the relative lack of
symptoms of the tumour until at an advanced stage of
the disease, as well as the high frequency ofportal vein
invasion and multiple intrahepatic metastases. Resec-
tional surgery is hazardous, and sometimes cannot be
applied, because of the presence of chronic liver dam-
age resulting from hepatitis B or C, alcoholism, and
cirrhosis in more than three quarters of patients with
HCC3. The use of screening employing serum alpha
fetoprotein and ultrasonography in high risk patients
has resulted in the detection of small asymptomatic
tumours and improved on the operability rate and the
long term survival rate.
In spite of the advances in chemotherapy, tumour
irradiation, alcohol injection, cryotherapy and trans-
arterial catheter embolisation, hepatic resection is
the only procedure which offers the hope of cure.104 A. TOYOSAKA et al.
Survival after liver resection is mainly affected by
two factors: the underlying liver disease and recur-
rence of the tumour4. Poor liver function is predictive
of late mortality, and more than half of the patients
in Child’s grade B and C died of progression of their
liver disease within one year without tumour recur-
rence5. In patients with good liver function, the long
term result of resection ofHCC is affected by the high
rate of intrahepatic recurrence, and only about 25 per
cent ofpatients survive to 8 years6. However, very high
cumulative intrahepatic recurrence reaching 100% at
5 years has also been reported4.
The present study by Toyosaka and his associates
sheds some light to the high incidences oftumour inva-
sion of the portal vein and the intrahepatic recurrences
after hepatic resection for HCC. These authors have
demonstrated very nicely that the mode ofHCC spread
progresses from invasion of the tumour capsule, to
extracapsular invasion, to vascular invasion and then
to intrahepatic metastasis. Their findings, also suggest
that intrahepatic invasion by HCC may occur through
the portal vein as an efferent tumour vessel. The fact
that intrahepatic metastasis was present in 57.1% of
tumour <5 cm in this study suggests that limited liver
resection for even smallHCC may not be adequate and
that adjuvant therapy after "curative" liver resection
for HCC should be evaluated by randomised studies.
W.Y. Lau
A.K.C. Li
Department of Surgery
The Chinese University of Hong Kong
Prince of Wales Hospital
Shatin, New Territories
Hong Kong
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